Eduardo Forleo‐Neto

2.0k total citations
22 papers, 769 citations indexed

About

Eduardo Forleo‐Neto is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Eduardo Forleo‐Neto has authored 22 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 6 papers in Microbiology and 5 papers in Infectious Diseases. Recurrent topics in Eduardo Forleo‐Neto's work include Influenza Virus Research Studies (10 papers), Respiratory viral infections research (9 papers) and Bacterial Infections and Vaccines (6 papers). Eduardo Forleo‐Neto is often cited by papers focused on Influenza Virus Research Studies (10 papers), Respiratory viral infections research (9 papers) and Bacterial Infections and Vaccines (6 papers). Eduardo Forleo‐Neto collaborates with scholars based in United States, Brazil and Switzerland. Eduardo Forleo‐Neto's co-authors include Albert D. M. E. Osterhaus, Bernadette G. van den Hoogen, Ron A. M. Fouchier, Rik L. de Swart, Patricia A. Cane, Sander Herfst, Ashwani Kumar Arora, Vas Narasimhan, Nancy Bermal and Uwe Nicolay and has published in prestigious journals such as The Journal of Infectious Diseases, Emerging infectious diseases and Vaccine.

In The Last Decade

Eduardo Forleo‐Neto

21 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eduardo Forleo‐Neto United States	13	658	347	118	94	81	22	769
Ulrich Behre Germany	16	695 1.1×	244 0.7×	98 0.8×	99 1.1×	156 1.9×	27	899
Masayoshi Shinjoh Japan	16	545 0.8×	280 0.8×	44 0.4×	52 0.6×	110 1.4×	57	711
Richard Nathan United States	6	526 0.8×	239 0.7×	119 1.0×	113 1.2×	19 0.2×	7	666
John Treanor United States	8	790 1.2×	264 0.8×	290 2.5×	76 0.8×	54 0.7×	8	1.0k
Laurence Fissette Belgium	10	580 0.9×	326 0.9×	150 1.3×	49 0.5×	32 0.4×	20	778
Mary Rinki United States	10	654 1.0×	181 0.5×	292 2.5×	154 1.6×	23 0.3×	10	893
Lidia Oostvogels Belgium	21	733 1.1×	353 1.0×	151 1.3×	80 0.9×	27 0.3×	40	1.2k
Tyler Bristol United States	9	597 0.9×	262 0.8×	169 1.4×	27 0.3×	18 0.2×	12	785
Jerry Labadie Netherlands	13	324 0.5×	127 0.4×	86 0.7×	87 0.9×	220 2.7×	22	561
N. A. Halsey United States	11	375 0.6×	183 0.5×	77 0.7×	135 1.4×	49 0.6×	13	517

Countries citing papers authored by Eduardo Forleo‐Neto

Since Specialization

Citations

This map shows the geographic impact of Eduardo Forleo‐Neto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Forleo‐Neto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Forleo‐Neto more than expected).

Fields of papers citing papers by Eduardo Forleo‐Neto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Forleo‐Neto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Forleo‐Neto. The network helps show where Eduardo Forleo‐Neto may publish in the future.

Co-authorship network of co-authors of Eduardo Forleo‐Neto

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Forleo‐Neto. A scholar is included among the top collaborators of Eduardo Forleo‐Neto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Forleo‐Neto. Eduardo Forleo‐Neto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Brien, Meagan P., Andrea T. Hooper, Eduardo Forleo‐Neto, et al.. (2023). Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection. Open Forum Infectious Diseases. 10(12). ofad598–ofad598. 1 indexed citations

Somersan-Karakaya, Selin, Eleftherios Mylonakis, Ernesto Oviedo‐Orta, et al.. (2023). Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double–Blind Trial. Open Forum Infectious Diseases. 10(5). ofad211–ofad211. 1 indexed citations

Brown, Elizabeth R., Meagan P. O’Brien, Flonza Isa, et al.. (2023). A Prospective Study of Key Correlates for Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2. Open Forum Infectious Diseases. 10(7). ofad271–ofad271.

Vanhoutte, Frédéric, Liang Su, Marcella Ruddy, et al.. (2020). Pharmacokinetics and Pharmacodynamics of Garetosmab (Anti‐Activin A): Results From a First‐in‐Human Phase 1 Study. The Journal of Clinical Pharmacology. 60(11). 1424–1431. 36 indexed citations

Bart, Stephan, et al.. (2016). Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study. Human Vaccines & Immunotherapeutics. 12(9). 2278–2288. 39 indexed citations

Johnston, William, Brandon Essink, Judith L. Kirstein, et al.. (2015). Comparative Assessment of a Single Dose and a 2-dose Vaccination Series of a Quadrivalent Meningococcal CRM-conjugate Vaccine (MenACWY-CRM) in Children 2–10 Years of Age. The Pediatric Infectious Disease Journal. 35(1). e19–e27. 7 indexed citations

Ervin, John, Donald M. Brandon, Eduardo Forleo‐Neto, et al.. (2015). Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial. International Journal of Infectious Diseases. 41. 65–72. 26 indexed citations

Frey, Sharon E., Humberto Reynales, Nancy Bermal, et al.. (2014). Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects. Vaccine. 32(39). 5027–5034. 110 indexed citations

Alberer, Martin, Gerd Burchard, Tomáš Jelı́nek, et al.. (2014). Safety and Immunogenicity of Typhoid Fever and Yellow Fever Vaccines When Administered Concomitantly With Quadrivalent Meningococcal ACWY Glycoconjugate Vaccine in Healthy Adults. Journal of Travel Medicine. 22(1). 48–56. 11 indexed citations

10.

Alberer, Martin, Gerd Burchard, Tomáš Jelı́nek, et al.. (2014). Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: A randomized, open-label, multi-center study. Travel Medicine and Infectious Disease. 12(5). 485–493. 15 indexed citations

11.

Nolan, Terry, Lulu Bravo, Ana Ceballos, et al.. (2014). Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59®-adjuvanted influenza vaccine in infants and young children. Vaccine. 32(46). 6146–6156. 46 indexed citations

12.

Alberer, Martin, Gerd Burchard, Tomáš Jelı́nek, et al.. (2014). Immunogenicity and Safety of Concomitant Administration of a Combined Hepatitis A/B Vaccine and a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults. Journal of Travel Medicine. 22(2). 105–114. 12 indexed citations

13.

Zedda, Luisanna, Eduardo Forleo‐Neto, André Vertruyen, et al.. (2014). Dissecting the Immune Response to MF59-adjuvanted and Nonadjuvanted Seasonal Influenza Vaccines in Children Less Than Three Years of Age. The Pediatric Infectious Disease Journal. 34(1). 73–78. 30 indexed citations

14.

Hoogen, Bernadette G. van den, Sander Herfst, Patricia A. Cane, et al.. (2004). Antigenic and Genetic Variability of Human Metapneumoviruses. Emerging infectious diseases. 10(4). 658–666. 316 indexed citations

15.

Paiva, Terezinha Maria de, et al.. (2000). Epidemiological study of Influenza virus in Brazil from 1996-1998.. 5(1). 5 indexed citations

16.

Araújo, Orlei Ribeiro de, Eduardo Forleo‐Neto, G N R Vespa, et al.. (2000). Associated or combined vaccination of Brazilian infants with a conjugate Haemophilus influenzae type b (Hib) vaccine, a diphtheria–tetanus–whole-cell pertussis vaccine and IPV or OPV elicits protective levels of antibodies against Hib. Vaccine. 19(2-3). 367–375. 11 indexed citations

17.

Weckx, Lily Yin, et al.. (1999). Safety of Simultaneous Pneumococcal and Influenza Vaccination in Elderly Patients in Brazil. Drugs & Aging. 15(Supplement 1). 43–45. 10 indexed citations

18.

Forleo‐Neto, Eduardo, C F de Oliveira, Eliane Mara Cesário Pereira Maluf, et al.. (1999). Decreased Point Prevalence ofHaemophilus influenzaeType b (Hib) Oropharyngeal Colonization by Mass Immunization of Brazilian Children Less Than 5 Years Old with Hib Polyribosylribitol Phosphate Polysaccharide–Tetanus Toxoid Conjugate Vaccine in Combination with Diphtheria‐Tetanus Toxoids–Pertussis Vaccine. The Journal of Infectious Diseases. 180(4). 1153–1158. 36 indexed citations

19.

Forleo‐Neto, Eduardo. (1997). Seroconversion of a trivalent measles, mumps, and rubella vaccine in children aged 9 and 15 months. Vaccine. 15(17-18). 1898–1901. 12 indexed citations

20.

Tavares‐Neto, José, et al.. (1988). Dados biométricos em esquistossomóticos adultos, Bahia (Brasil). Revista de Saúde Pública. 22(4). 288–291. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact